SURVYR

IDXX

IDEXX Laboratories, Inc.
$561.25
−$8.96 (1.57%)Oct 27 close
Health CareS&P 500 CompareTechnicals
-23%-12%-2%+9%+19%Oct 2025Oct 2026Apr 202652w high $769.9852w low $500.61
IDXXSPY
Wall St. Highest PT $805.00 (+43.4%) Wall St. Avg PT $698.00 (+24.4%)
$505$627$748$870$992POC $570Hi $805Avg $698
Underwater Drawdown %Max DD -34.2%Current -26.8%
0.0%-34.2%
Relative Strength vs SPY-26.8% vs SPYUnderperforming
+42%0%-42%
1W
+$3.32 (0.60%)
1M
+$41.99 (8.09%)
3M
−$8.29 (1.46%)
6M
−$7.05 (1.24%)
YTD
−$115.28 (17.04%)
1Y
−$86.15 (13.31%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
12 analysts · mean score 2.07
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$561.25
Average target$698.00
+$136.75 (+24.4%) upsideaverage target vs current price
CurrentAverageMedian
Low$470.00
Median$698.00
High$805.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$43.6B
P/E (last 12 months)38.9
P/E (next 12 months, estimated)33.1
52-week range$500.61 – $769.98
Revenue growth (latest quarter vs a year ago)+9.7%
Dividend yieldNo dividend
Analyst consensusBuy (12)
Average analyst price target$698.00 (+24%)

What they do

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis.

Healthcare · Diagnostics & Research
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
17th percentile in sector
D
12-1 return: -17.0%
Percentile within its GICS sector across the S&P 1500.
Growth
57th percentile in sector
B-
Revenue growth (YoY): +9.7%
Percentile within its GICS sector across the S&P 1500.
Value
14th percentile in sector
D-
Forward E/P: 3.0% · EBITDA/EV: 3.6%
Percentile within its GICS sector across the S&P 1500.
Profitability
91st percentile in sector
A
Profit margin: +25.0% · Return on equity: +74.2%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
ranked 413 of 499 · 12-month momentum -12.9%
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
SURVYR. Long Book
Not in the current book

Earnings & events

IDXX earningsNext report in 6 days
Next report · quarter Sep 2026
Mon Nov 2, 2026Before the open
EPS consensus$3.72
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 4, 2026$4.27est $3.93+8.5%Above estimates
May 5, 2026$3.47est $3.41+1.7%Above estimates
Feb 2, 2026$3.08est $2.94+4.8%Above estimates
Nov 3, 2025$3.40est $3.15+8.1%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 18:15:12 ET
24-1025-0225-0525-0825-1126-0226-0526-080.004.27
EstimateActual (beat)Actual (miss)

News & catalysts

More news
IDEXX Laboratories (IDXX) Rebounds On Jefferies Support, Is It Still 20% Undervalued?
Simply Wall St. · Oct 21
Idexx Laboratories Now #251 Largest Company, Surpassing Waters
Nasdaq · Oct 20
Insider trades
Kingsley Lawrence D
Director · 2026-09-04
Sell
$1.2M
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:15:12 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026